These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27152654)

  • 21. Evolving modalities for femoropopliteal interventions.
    Ansel GM; Lumsden AB
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II82-97. PubMed ID: 19624076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease.
    Sarode K; Spelber DA; Bhatt DL; Mohammad A; Prasad A; Brilakis ES; Banerjee S
    JACC Cardiovasc Interv; 2014 Aug; 7(8):827-39. PubMed ID: 25147028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Rosenfield K; Jaff MR; White CJ; Rocha-Singh K; Mena-Hurtado C; Metzger DC; Brodmann M; Pilger E; Zeller T; Krishnan P; Gammon R; Müller-Hülsbeck S; Nehler MR; Benenati JF; Scheinert D;
    N Engl J Med; 2015 Jul; 373(2):145-53. PubMed ID: 26106946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Femoropopliteal in-stent restenosis: review and potential for drug based therapy.
    Phillips J; Ansel G
    J Cardiovasc Surg (Torino); 2013 Jun; 54(3):333-6. PubMed ID: 23640356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique demands of the femoral anatomy and pathology and the need for unique interventions.
    Otsuka F; Nakano M; Sakakura K; Ladich E; Kolodgie FD; Virmani R
    J Cardiovasc Surg (Torino); 2013 Apr; 54(2):191-210. PubMed ID: 23558655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
    Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D
    JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Femoropopliteal in-stent restenosis: current treatment strategies.
    Singh GD; Armstrong EJ; Laird JR
    J Cardiovasc Surg (Torino); 2014 Jun; 55(3):325-33. PubMed ID: 24755700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-Coated Balloons: Current Outcomes and Future Directions.
    Kondapalli A; Danek BA; Khalili H; Jeon-Slaughter H; Banerjee S
    Interv Cardiol Clin; 2017 Apr; 6(2):217-225. PubMed ID: 28257769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug eluting balloons.
    Diehm NA; Hoppe H; Do DD
    Tech Vasc Interv Radiol; 2010 Mar; 13(1):59-63. PubMed ID: 20123434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
    Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
    EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which is currently the best strategy for treatment of SFA in-stent restenosis?
    Elens M; Verbist J; Keirse K; Van Den Eynde W; Peeters P
    J Cardiovasc Surg (Torino); 2014 Aug; 55(4):477-81. PubMed ID: 24941234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-eluting stents and drug-coated balloons in peripheral artery disease.
    Buechel R; Stirnimann A; Zimmer R; Keo H; Groechenig E
    Vasa; 2012 Jul; 41(4):248-61. PubMed ID: 22825858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
    Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
    J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting technologies in femoral artery lesions.
    Deloose K; Lauwers K; Callaert J; Maene L; Keirse K; Verbist J; Peeters P; Bosiers M
    J Cardiovasc Surg (Torino); 2013 Apr; 54(2):217-24. PubMed ID: 23558657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group.
    Kleber FX; Rittger H; Bonaventura K; Zeymer U; Wöhrle J; Jeger R; Levenson B; Möbius-Winkler S; Bruch L; Fischer D; Hengstenberg C; Pörner T; Mathey D; Scheller B
    Clin Res Cardiol; 2013 Nov; 102(11):785-97. PubMed ID: 23982467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
    Bosiers M; Deloose K; Callaert J; Verbist J; Hendriks J; Lauwers P; Schroë H; Lansink W; Scheinert D; Schmidt A; Zeller T; Beschorner U; Noory E; Torsello G; Austermann M; Peeters P
    J Endovasc Ther; 2015 Feb; 22(1):1-10. PubMed ID: 25775672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-coated balloons are replacing the need for nitinol stents in the superficial femoral artery.
    Kitrou P; Karnabatidis D; Katsanos K
    J Cardiovasc Surg (Torino); 2016 Aug; 57(4):569-77. PubMed ID: 27128105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of the 2014 Food and Drug Administration Circulatory System Devices Panel meeting regarding the Lutonix® drug coated balloon.
    Escárcega RO; Waksman R
    Cardiovasc Revasc Med; 2014; 15(8):402-7. PubMed ID: 25499024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel balloon technologies to minimize dissection of peripheral angioplasty.
    Spiliopoulos S; Karamitros A; Reppas L; Brountzos E
    Expert Rev Med Devices; 2019 Jul; 16(7):581-588. PubMed ID: 31149847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.